Urease inhibitors as potential drugs for gastric and urinary tract infections: A patent review

Expert Opinion on Therapeutic Patents

Volumn 21, Issue 6, 2011, Pages 945-957

  Kosikowska, Paulina ^a   Berlicki, Łukasz ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

gastric tract; Helicobacter pylori; infections; urease inhibitors; urinary tract

Indexed keywords

1,2 BENZISOTHIAZOLE 3(2H) ONE; 1,2,4 TRIAZOLE 3 THIONE; 1,3,4 OXADIAZOLE 2(3H) THIONE; 1,3,4 THIADIAZOLE 2(3H) THIONE; 4 (4 HYDROXYPHENYLETHYL)PYROGALLOL; 5 [4 (HYDROXY)PHENYL] 1,3,4 THIADIAZOLE 2(3H) THIONE; ACETOHYDROXAMIC ACID; BENZIMIDAZOLE; HYDROXAMIC ACID; HYDROXYUREA; IMIDAZOLE DERIVATIVE; LANSOPRAZOLE; METHYLUREA; METRONIDAZOLE; OMEPRAZOLE; OXAZOLE DERIVATIVE; PHOSPHORAMIDIC ACID; PHOSPHORIC ACID DERIVATIVE; POLYPHENOL DERIVATIVE; PYRAZOLE DERIVATIVE; QUINONE DERIVATIVE; RABEPRAZOLE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; UREA DERIVATIVE; UREASE; UREASE INHIBITOR;

ANTIBIOTIC THERAPY; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; BACTERIAL GENE; BACTERIAL GROWTH; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HELICOBACTER INFECTION; HEPATIC ENCEPHALOPATHY; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA; KLEBSIELLA INFECTION; NEUROLOGIC DISEASE; NONHUMAN; PROTEUS; PROTEUS INFECTION; PSEUDOMONAS; PSEUDOMONAS INFECTION; PYELONEPHRITIS; REVIEW; SKIN DISEASE; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; STOMACH DISEASE; TERATOGENICITY; URINARY TRACT INFECTION; UROLITHIASIS;

AMIDES; ENZYME INHIBITORS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROXAMIC ACIDS; PATENTS AS TOPIC; PHOSPHORIC ACIDS; UREA; UREASE; URINARY TRACT INFECTIONS;

EID: 79956222404     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2011.574615     Document Type: Review

References (124)

1. Mobley HL, Hausinger RP. Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev 1989;53:85-108 (Pubitemid 19080948)
2. Krajewska B, Ureases I. Functional, catalytic and kinetic properties: a review. J Mol Cat B 2009;59:9-21
3. Zerner B. Recent advances in the chemistry of an old enzyme, urease. Bioorg Chem 1991;19:116-31
4. Blakeley RL, Treston A, Andrews RK, et al. Nickel(II)-promoted ethanolysis and hydrolysis of N-(2-pyridylmethyl) urea. A model for urease. J Am Chem Soc 1982;104:612-14
5. Shaw WHR, Bordeaux JJ. The Decomposition of urea in aqueous media. J Am Chem Soc 1955;77:4729-33
6. Callahan BP, Yunan Y, Wolfenden R. The burden borne by urease. J Am Chem Soc 2005;127:10828-9 (Pubitemid 41129848)
7. Estiu G, Merz KM Jr. The hydrolysis of urea and the proficiency of urease. J Am Chem Soc 2004;126:6932-44 (Pubitemid 38855392)
8. Karplus PA, Pearson MA, Hausinger RP. 70 Years of crystalline urease: what have we learned? Acc Chem Res 1997;30:330-7 (Pubitemid 127472588)
9. Mobley HLT, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev 1995;59:451-80
10. Amtul Z, Atta-ur-Rahman, Siddiqui RA, et al. Chemistry and mechanism of urease inhibition. Curr Med Chem 2002;9:1323-48 (Pubitemid 34759887)
11. Benini S, Rypniewski WR, Wilson KS, et al. A new proposal for urease mechanism based on the crystal structures of the native and inhibited enzyme from Bacillus pasteurii: why urea hydrolysis costs two nickels. Struct Fold Des 1999;7:205-16 (Pubitemid 29159705)
12. Jabri E, Carr MB, Hausinger RP, et al. The crystal structure of urease from Klebsiella aerogenes. Science 1995;268:998-1004
13. Pearson MA, Hausinger RP, Karplus PA. Crystallographic studies of the nickel metalloenzyme urease and insights into the catalytic mechanism. J Inorg Biochem 1997;67:179
14. Dunn BE, Grutter MG. Helicobacter pylori springs another surprise. Nat Struct Biol 2001;8:480-2 (Pubitemid 32525001)
15. Benini S, Rypniewski WR, Wilson KS, et al. The complex of Bacillus pasteurii urease with acetohydroxamate anion from X-ray data at 1.55 A resolution. J Biol Inorg Chem 2000;5:110-18 (Pubitemid 30120594)
16. Follmer C. Insights into the role and structure of plant ureases. Phytochemistry 2008;69:18-28 (Pubitemid 350262817)
17. Schafer UK, Kaltwasser H. Urease from Staphylococcus saprophyticus: purification, characterization and comparison to Staphylococcus xylosus urease. Arch Microbiol 2008;161:393-9
18. Pinkse MWH, Maier CS, Kim J-I, et al. Macromolecular assembly of Helicobacter pylori urease investigated by mass spectrometry. J Mass Spectrom 2003;38:315-20 (Pubitemid 36395770)
19. McCarty GW, Bremner JM. Production of urease by microbial activity in soils under aerobic and anaerobic conditions. Biol Fertil Soils 1991;11:228-39
20. Sahrawat KL. Control of urea hydrolysis and nitrification in soil by chemicals. Prospects and problems. Plant Soil 1980;57:335-52
21. Bremner JM, Krogmeier MJ. Evidence that the adverse effect of urea fertilizer on seed germination in soil is due to ammonia formed through hydrolysis of urea by soil urease. Proc Natl Acad Sci USA 1989;86:8185-8
22. Jacobsen SM, Stickler DJ, Mobley HLT, et al. Complicated catheter associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008;21:26-59 (Pubitemid 351160009)
23. Andersen LP. Colonization and infection by Helicobacter pylori in humans. Helicobacter 2007;12:12-15 (Pubitemid 350076230)
24. Follmer C. Ureases as a target for the treatment of gastric and urinary infections. J Clin Pathol 2010;63:424-30
25. Graham DY, Malaty HM, Evans DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterol 1991;100:1495-501
26. Covacci A, Telford JL, Del Giudica G, et al. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328-33 (Pubitemid 29289653)
27. Eaton KA, Brooks CL, Morgan DR, et al. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991;59:2470-5
28. Phadnis SH, Parlow MH, Levy M, et al. Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect Immun 1996;64:905-12 (Pubitemid 26065566)
29. Stingl K, Sltendorf K, Bakker EP. Acid survival of Helicobacter pylori: how does urease activity trigger cytoplasmic pH homeostasis? Trends in Microbiol 2002;10:70-4 (Pubitemid 34119342)
30. Mobley HLT, Mendz GL, Hazell SL, editors, Helicobacter pylori. Physiology and Genetics. ASM Press, Washington (DC); 2001
31. Krishnamurthy P, Parlow M, Zitzer JB, et al. Helicobacter pylori containing only cytoplasmic urease is susceptible to acid. Infect Immun 1998;66:5060-6 (Pubitemid 29044591)
32. Scott DR, Weeks D, Hong C, et al. The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterol 1998;114:58-70 (Pubitemid 28020955)
33. Evans DJ Jr, Evans DG, Kirkpatrick SS, et al. Characterization of the Helicobacter pylori urease and purification of its subunits. Microb Pathog 1991;10:15-26
34. Ham NC, Oh ST, Sung JY, et al. Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Biol 2001;8:505-9 (Pubitemid 32525008)
35. Hu LT, Foxall PA, Russell R, et al. Purification of recombinant Helicobacter pylori urease apoenzyme encoded by ureA and ureB. Infect Immun 1992;60:2657-66
36. Park IS, Hausinger RP. Evidence for the presence of urease apoprotein complexes containing UreD, UreF, and UreG in cells that are competent for in vivo enzyme activation. J Bacteriol 1995;177:1947-51
37. Scott DR, Marcus EA, Weeks DL, et al. Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease. Infect Immun 2000;68:470-7 (Pubitemid 30056496)
38. Rektorschek M, Buhmann A, Weeks D, et al. Acid resistance of Helicobacter pylori depends on the UreI membrane protein and an inner membrane proton barrier. Mol Microb 2000;36:141-52 (Pubitemid 30195396)
39. Skouloubris S, Thiberge J-M, Labigne A, et al. The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect Immun 1998;66:4517-21 (Pubitemid 28402735)
40. Pasteur Institut. Methods of inhibiting Helicobacter pylori. US6190667; 2001
41. Burne RA, Chen YM. Bacterial ureases in infectious diseases. Microb Infect 2000;2:533-42 (Pubitemid 30387207)
42. Hinman F. Directional growth of renal calculi. J Urol 1979;121:700-5
43. Bichler K-H, Eipper E, Naber K, et al. Urinary infection stones. Int J Antimicrob Agents 2002;19:488-98 (Pubitemid 34831653)
44. Musher DM, Griffith DP, Yawn D, et al. Role of Urease in pyelonephritis resulting from urinary tract infection with Proteus. J Infect Dis 1975;131:177-81
45. Nicolle LE. Epidemiology of urinary tract infections. Clin Microb News 2002;24:135-40
46. Samtoy B, DeBeukelaer MM. Ammonia encephalopathy secondary to urinary tract infection with Proteus mirabilis. Pediatrics 1980;65:294-7 (Pubitemid 10068590)
47. Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated Pyelonephritis. Urol Clin North Am 2008;35:1-12 (Pubitemid 350166517)
48. Hellerstein S. Antibiotic treatment for urinary tract infections in pediatric patients. Minerva Pediatr 2003;55:395-406 (Pubitemid 37474676)
49. Kobashi K, Hase J, Uehare K. Specific inhibition of urease by hydroxamic acids. Biochim Biophys Acta 1962;65:380-3
50. Fishbein WN, Carbone PP. Urease Catalysis: II. Inhibition of the enzyme by hydroxyurea, hydroxylamine, and acetohydroxamic acid. J Biol Chem 1965;240:2407-14
51. Kobashi K, Hase J, Komai T. Evidence for the formation of an inactive urease-hydroxamic acid complex. Biochem Biophys Res Commun 1966;23:34-8
52. Hase J, Kobashi K. Inhibition of Proteus vulgaris urease by hydroxamic acids. J Biochem (Tokyo) 1967;62:293-9
53. Blakeley RL, Hinds JA, Kunze HE, et al. Jack bean urease (EC 3.5.1.5). Demonstration of a carbamoyl-transfer reaction and inhibition by hydroxamic acids. Biochemistry 1969;8:1991-2000
54. Kobashi K, Kumaki K, Hase J. Effect of acyl residues of hydroxamic acids on urease inhibition. Biochim Biophys Acta 1971;227:429-41
55. Kumaki K, Tomoka S, Kobashi K, et al. Structure-activity correlations between hydroxamic acids and their inhibitory powers on urease activity. I. A quantitative approach to the effect of hydrophobic character of acyl residue. Chem Pharm Bull 1972;20:1599-606
56. Griffith DP, Musher DM. Method and composition for treating urinary tract infections US4024256; 1977
57. Griffith DP, Gibson JR, Clinton CW, et al. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. J Urol 1978;119:9-15 (Pubitemid 8271395)
58. Griffith DP, Musher DM. Acetohydroxamic acid. Potential use in urinary infection caused by urea-splitting bacteria. Urology 1975;5:299-302
59. Griffith DP, Khonsari F, Skurnick JH, et al. A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients. J Urol 1988;140:318-24
60. Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med 1984;311:760-4 (Pubitemid 14026226)
61. Griffith DP, Gleeson MJ, Lee H, et al. Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur Urol 1991;20:243-7
62. Bailie NC, Osborne CA, Leininger JR, et al. Teratogenic effect of acetohydroxamic acid in clinically normal beagles. Am J Vet Res 1986;47:2604-11 (Pubitemid 17222324)
63. Kobashi K, Takebe S, Terashima N, et al. Inhibition of urease activity by hydroxamic acid derivatives of amino acids. J Biochem (Tokyo) 1975;77:837-43
64. Munakata K, Tanaka S, Toyoshima S. Theraphy for urolithiasis with hydroxamic acids. I. Synthesis of new N-(aroyl)glycinohydroxamic acid derivatives and related compounds. Chem Pharm Bull 1980;28:2045-51
65. Kobashi K, Munakata K, Takebe S, et al. Therapy for urolithiasis by hydroxamic acids. II. Urease inhibitory potency and urinary excretion rate of hippurohydroxamic acid derivatives. J Pharmacobiodyn 1980;3:444-50 (Pubitemid 11206300)
66. Morton Norwich Products, Inc. 2-p-nitro- or p- chlorobenzamidoacetohydroxamic acid. US3787569; 1974
67. Andersen JA. Benurestat, a urease inhibitor for the therapy of infected ureolysis. Invest Urol 1975;12:381-6
68. Eisai Co. Ltd. Novel hydroxamic acid derivatives and medicaments for treatment of urolithiasis and pyelonephrosis comprising such derivatives. US4083996; 1978
69. Munakata K, Mochida H, Kondo S, et al. Mutagenicity of N-acylglycinohydroxamic acids and related compounds. J Pharmacobiodyn 1980;3:557-61 (Pubitemid 11132538)
70. Satoh M, Munakata K, Takeuchi H, et al. Evaluation of effects of novel urease inhibitor, N-(pivaloyl)glycinohydroxamic acid on the formation of an infection bladder stone using a newly designed urolithiasis modell in rats. Chem Pharm Bull 1991;39:894-6
71. Eisai Co. Ltd. Novel hydroxamic acid compounds, method for preparation thereof and medicaments containing such compounds. US4256765; 1981
72. Munakata K, Kobashi K, Takebe S, et al. Therapy for urolithiasis by hydroxamic acids. III. Urease inhibitory potency and urinary excretion rate of N-acylglycinohydroxamic acids. J Pharmacobiodyn 1980;3:451-6 (Pubitemid 11206301)
73. Takeuchi H, Okada Y, Kobashi K, et al. Treatment of infected urinary stones in rats by a new hydroxamic acid, ?N-(Pivaroyl)glycinohydroxamic acid?. Urol Res 1982;10:217-19 (Pubitemid 12035525)
74. Asahi Chem Ind Co. Ltd. Hydroxamic acid derivative, enzyme inhibitor and antiulcer agent. JP4217950; 1992
75. Dixon NE, Gazzola C, Watters JJ, et al. Inhibition of jack bean urease (EC 3.5.1.5) by acetohydroxamic acid and by phosphoramidate. Equivalent weight for urease. J Am Chem Soc 1975;97:4130-1
76. Andrews RK, Dexter A, Blakeley RL, et al. Jack bean urease (EC 3.5.1.5) VIII. On the inhibition of urease by amides and esters of phosphoric acid. J Am Chem Soc 1986;108:7124-5
77. Morton Norwich Products, Inc. N-[Diaminophosphinyl]arylcarboxamides. US4182881; 1980
78. Morton Norwich Products, Inc. Phosphorotriamides as urease inhibitors. US4242325; 1980
79. Morton Norwich Products, Inc. 8-[(4-Aminophenyl)sulfonyl]amino-2- naphthalenyl phosphorodiamidate. US4225526; 1980
80. Morton Norwich Products, Inc. [[(4-Aminophenyl)sulfonyl]amino]phenyl phosphorodiamidates. US4222948; 1980
81. Takeda Chemical Industries Ltd. Phosphorylamides, their preparation and use. US5840917; 1998
82. Faraci WS, Yang BV, O?Rourke D, et al. Inhibition of Helicobacter pylori urease by phenyl phosphorodiamidates: mechanism of action. Bioorg Med Chem 1995;3:605-10
83. Pope AJ, Toseland CD, Rushant B, et al. Effect of potent urease inhibitor, fluorofamide, on Helicobacter sp. in vivo and in vitro. Dig Dis Sci 1998;43:109-19 (Pubitemid 28081650)
84. Vassiliou S, Grabowiecka A, Kosikowska P, et al. Design, synthesis and evaluation of novel organophosphorus inhibitors of bacterial ureases. J Med Chem 2008;51:5736-44
85. Vassiliou S, Kosikowska P, Grabowiecka A, et al. Computer-aided optimization of phosphinic inhibitors of bacterial ureases. J Med Chem 2010;53:5597-606
86. Shaw WHR, Raval DN. The inhibition of urease by methylurea. J Am Chem Soc 1961;83:2866-8
87. Uesato S, Hashimoto Y, Nishino M, et al. N-Substituted hydroxyureas as urease inhibitors. Chem Pharm Bull (Tokyo) 2002;50:1280-2 (Pubitemid 41656850)
88. Sivapriya K, Suguna P, Banerjee A, et al. Facile one-pot synthesis of thio and selenourea derivatives: a new class of potent urease inhibitors. Bioorg Med Chem Lett 2007;17:6387-91 (Pubitemid 47552802)
89. Perveen Shahnaz. Process for the preparation of ?Urchym? a urease and alpha-chymotrypsin enzyme inhibitory drug. US221214; 2008
90. Zaborska W, Kot M, Superata K. Inhibition of Jack Bean urease by 1,4-benzoquinone and 2,5-dimethyl-1,4-benzoquinone. Evaluation of the inhibition mechanism. J Enzyme Inh Med Chem 2002;17:247-53 (Pubitemid 35189539)
91. Tanaka T, Kawase M, Tani S. Urease inhibitory activity of simple a, b-unsaturated ketones. Life Sci 2003;73:2985-90 (Pubitemid 37176890)
92. Ashiralieva A, Kleiner D. Polyhalogenated benzo- and naphthoquinones are potent inhibitors of plant and bacterial ureases. FEBS Lett 2003;555:367-70 (Pubitemid 37486057)
93. Kleiner D, Ashiralieva A. Use of quinones and their derivatives as urease inhibitors, particularly for treating infections with urease-producing bacteria, e.g., Helicobacter pylori. DE10333448; 2005
94. BIO21 KK. Urease inhibitor composition, food and beverage and cosmetics containing the same. JP070229; 2007
95. Ichimaru Pharcos, Inc. Urease inhibitor. JP2006193477; 2006
96. Nagase Co. Ltd. Urease inhibitor. JP2006219376; 2006
97. Nagase Co. Ltd. Urease inhibitor. JP2006241039; 2006
98. Yakult Honsha Co. Ltd. Urease activity inhibitor. JP48844; 2003
99. Xiao Z-P, Shi D-H, Li H-Q, et al. Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease. Bioorg Med Chem 2007;15:3703-10 (Pubitemid 46661802)
100. Tanaka T, Kawase M, Tani S. aHydroxyketones as- inhibitors of urease. Bioorg Med Chem 2004;12:501-5
101. Jishou University. 1,2-diphenylethane type urease inhibitor and synthesis and applications thereof. CN101665413; 2010
102. Xiao ZP, Ma TW, Fu WC, et al. The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors. Eur J Med Chem 2010;45:5064-70
103. Dajani EZ, Klamut MJ. Novel therapeutic approaches to gastric and duodenal ulcers: an update. Expert Opin Invest Drugs 2000;9:1537-44 (Pubitemid 30433713)
104. Nagaya H, Satoh H, Kubo K, et al. Possible mechanism for the inhibition of gastric (H+/K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749. J Pharmacol Exp Ther 1989;248:799-805 (Pubitemid 19090257)
105. Sjostrom JE, Kuhler T, Larsson H. Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp. Antimicrob Agents Chemother 1997;41:1797-801 (Pubitemid 27339890)
106. Kühler TC, Fryklund J, Bergman N, et al. Structure-activity relationship of omeprazole and analogs as Helicobacter pylori urease inhibitors. J Med Chem 1995;38:4906-16
107. Takeda Chemical Industries Ltd. Urease inhibitor. JP7025767; 1995
108. Nagata K, Satoh H, Iwahi T, et al. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob Agents Chemother 1993;37:769-74 (Pubitemid 23096876)
109. Tsuchiya M, Imamura L, Park J-B, et al. Helicobacter Pylori urease inhibition by rabeprazole, a proton pump inhibitor. Biol Pharm Bull 1995;18:1053-6
110. Eisai Co. Ltd. Antiurease agent. JP7118153; 1995
111. Haessle AB. Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation. EU5129; 1978
112. Takeda Chemical Industries Ltd. Pyridine derivatives and their production. EU174726; 1986
113. Eisai Co. Ltd. Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same. EU268956; 1988
114. Nippon Chemiphar Co. Benzimidazole derivatives. DE3531487; 1986
115. Toa Eiyo Ltd. Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same. EU434999; 1991
116. Ems SA. Antibacterial and/or antiprotozoal nitromidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines. US072929; 2007
117. Otsuka Pharma Co. Ltd. Urease inhibitors. US058952; 2004
118. Kajiwara M. Urease inhibitors. US060482; 2003
119. Amtul Z, Rasheed M, Choudhary MI, et al. Kinetics of novel competitive inhibitors of urease enzymes by a focused library of oxadiazoles/thiadiazoles and triazoles. Biochem Biophys Res Comm 2004;319:1053-63 (Pubitemid 38739426)
120. Viamet Pharmaceuticals, Inc. Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties. US256082; 2010
121. Chen W, Li Y, Cui Y, et al. Synthesis, molecular docking and biological evaluation of Schiff base transition metal complexes as potential urease inhibitors. Eur J Med Chem 2010;45:4473-8
122. You Z-L, Ni L-L, Shi D-H, et al. Synthesis, structures, and urease inhibitory activities of three copper(II) and zinc(II) complexes with 2-{[2-(2-hydroxyethylamino)ethylimino] methyl}-4-nitrophenol. Eur J Med Chem 2010;45:3196-9
123. You Z-L, Zhang L, Shi D-H, et al. Synthesis, crystal structures and urease inhibitory activity of copper(II) complexes with Schiff bases. Inorg Chem Commun 2010;13:996-8
124. Griffith DP. Urease stones. Urol Res 1979;7:215-21 (Pubitemid 10085038)